1. Home
  2. COEP vs INTG Comparison

COEP vs INTG Comparison

Compare COEP & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • INTG
  • Stock Information
  • Founded
  • COEP 2017
  • INTG 1965
  • Country
  • COEP United States
  • INTG United States
  • Employees
  • COEP N/A
  • INTG N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • INTG Building operators
  • Sector
  • COEP Health Care
  • INTG Real Estate
  • Exchange
  • COEP Nasdaq
  • INTG Nasdaq
  • Market Cap
  • COEP 32.0M
  • INTG 28.9M
  • IPO Year
  • COEP N/A
  • INTG N/A
  • Fundamental
  • Price
  • COEP $8.95
  • INTG $11.96
  • Analyst Decision
  • COEP
  • INTG
  • Analyst Count
  • COEP 0
  • INTG 0
  • Target Price
  • COEP N/A
  • INTG N/A
  • AVG Volume (30 Days)
  • COEP 28.9K
  • INTG 1.3K
  • Earning Date
  • COEP 05-14-2025
  • INTG 05-15-2025
  • Dividend Yield
  • COEP N/A
  • INTG N/A
  • EPS Growth
  • COEP N/A
  • INTG N/A
  • EPS
  • COEP N/A
  • INTG N/A
  • Revenue
  • COEP $62,874.00
  • INTG $61,597,000.00
  • Revenue This Year
  • COEP N/A
  • INTG N/A
  • Revenue Next Year
  • COEP N/A
  • INTG N/A
  • P/E Ratio
  • COEP N/A
  • INTG N/A
  • Revenue Growth
  • COEP N/A
  • INTG 6.76
  • 52 Week Low
  • COEP $2.31
  • INTG $10.18
  • 52 Week High
  • COEP $13.70
  • INTG $22.84
  • Technical
  • Relative Strength Index (RSI)
  • COEP 45.20
  • INTG 48.90
  • Support Level
  • COEP $9.14
  • INTG $10.18
  • Resistance Level
  • COEP $9.82
  • INTG $12.38
  • Average True Range (ATR)
  • COEP 0.54
  • INTG 0.51
  • MACD
  • COEP -0.06
  • INTG -0.03
  • Stochastic Oscillator
  • COEP 21.51
  • INTG 58.36

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: